{"id":"W4408032428","doi":"10.3390/curroncol32030142","title":"Optimal Use of Bispecific Antibodies for the Treatment of Diffuse Large B-Cell Lymphoma in Canada","year":2025,"lang":"en","type":"review","venue":"Current Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Fluidigm (Canada); University of Ottawa; University of Calgary; Université de Montréal","funders":"AbbVie Canada","keywords":"Bispecific antibody; Medicine; Lymphoma; Antibody; Chimeric antigen receptor; Diffuse large B-cell lymphoma; Oncology; Refractory (planetary science); Cancer research; Internal medicine; Immunotherapy; Immunology; Cancer; Monoclonal antibody; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007262193,0.0004557927,0.0009131068,0.001836243,0.0001937831,0.0007073237,0.0007202908,0.0008688825,0.002637593],"category_scores_gemma":[0.0007305469,0.0002397024,0.0004936968,0.001197646,0.0003227256,0.0009203885,0.0004336321,0.001409695,0.001212572],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007316114,"about_ca_system_score_gemma":0.001174022,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00194786,"about_ca_topic_score_gemma":0.004353014,"domain_scores_codex":[0.9998031,0.00003986343,0.0000340245,0.00002745347,0.0000744705,0.00002111574],"domain_scores_gemma":[0.9997516,0.0001071038,0.0000463073,0.00000553645,0.00007021904,0.00001914081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001038024,0.00004044411,0.0001298936,0.01571039,0.00008879152,0.0001540968,0.00003726692,0.0002074716,0.001098136,0.002059861,0.02237149,0.9579985],"study_design_scores_gemma":[0.00004766222,0.0001270214,0.0007111352,0.00698029,0.0001611806,0.001269621,0.00004470803,0.00009113934,0.0005026156,0.001078193,0.9889726,0.00001386211],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007535403,0.9991838,0.00004106644,0.0001873866,0.00007178103,0.000003048877,0.000006428297,0.00000274487,0.0004283834],"genre_scores_gemma":[0.0006947115,0.9986446,0.0001015046,0.0002151049,0.00006195877,0.000004110404,0.0000170729,9.856807e-7,0.0002599101],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9980521,"threshold_uncertainty_score":0.008823633,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2203581579266412,"score_gpt":0.458813131530672,"score_spread":0.2384549736040308,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}